Data as of Nov 4, 2026.
BIOY vs TYLG: Dividend Yield & Total Return
BIOY and TYLG both write options for income.
askIQ about this page
askIQ about BIOY and TYLG
Net assets: $1.5m on Nov 3, 2026 for GraniteShares YieldBOOST Biotech ETF, and $17m on Oct 12, 2026 for Global X Information Technology Covered Call & Growth ETF.
13.6 pts behind XBI
BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.
XBI
+19.0%
BIOY
+5.4%
26.1% as cash
13.6 pts behind XBI
Total return, distributions reinvested
13.6 pts behind XBI
BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.
XBI
+19.0%
BIOY
+5.4%
13.6 pts behind XBI
26.1% of it arrived as cash. Total return, distributions reinvested. BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.
Data to Nov 4, 2026.Not measured
TYLG over 1 year: paid 10.2%, price +9.3%, total +20.4%, not measured against a benchmark. Data to Nov 4, 2026.
TYLG
+20.4%
10.2% of it arrived as cash
Total return, distributions reinvested
Not measured
TYLG over 1 year: paid 10.2%, price +9.3%, total +20.4%, not measured against a benchmark. Data to Nov 4, 2026.
TYLG
+20.4%
10.2% of it arrived as cash. Both charts share one scale, with zero at the line. TYLG over 1 year: paid 10.2%, price +9.3%, total +20.4%, not measured against a benchmark. Data to Nov 4, 2026.
Data to Nov 4, 2026.Pair scorecard
TYLG costs 0.58 points a year less; TYLG is 12.1 times larger.
Points (pts) are percentage points.
| Measure | BIOY | TYLG |
|---|---|---|
| Paid and earned | ||
| Total return, 1 year | not published | +20.4% |
| Price change | fell 21.9% (since May 5, 2026) | rose 9.3% (1 year) |
| Return of capital, issuer estimate | 96% of the Sep 22, 2026 payment | 100% of the Sep 24, 2026 payment |
| Against its benchmark | ||
| Benchmark | Biotech, measured through XBI | not published |
| Cost and size | ||
| Expense ratio | 1.18% | 0.60% |
| Net assets, as of Oct 12, 2026 | $1.4m | $17m |
| Holdings | ||
| Holdings in common | 0% | |
What they share
By the books each fund has filed, BIOY and TYLG hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Jul 31, 2026.
half
0% in common
Only in one fund ↓
Side by side
As of Nov 4, 2026. Source: ETFIQ. Cash paid: distributions over the window, as a share of the starting price. Payout rate: the latest payment, annualized, over today’s price.
Window by window
| Total return | Cash paid | Against the benchmark | ||||
|---|---|---|---|---|---|---|
| Window | BIOY | TYLG | BIOY | TYLG | BIOY | TYLG |
| 3 months | +6.9% | −1.2% | 14.5% | 2.3% | +2.9 pts | not measured |
| 6 months | +4.4% | +6.1% | 25.9% | 5.3% | −11.3 pts | not measured |
| 1 year | – | +20.4% | – | 10.2% | – | not measured |
| 3 years | – | +82.8% | – | 35.5% | – | not measured |
| Since launchNot the same days: BIOY May 2026 · TYLG Nov 2022 | +5.4% | +130.4% | 26.1% | 48.5% | −13.7 pts | not measured |
– means no data for this window. Open this comparison in the app →
BIOY
Over the period from its first trade on May 5, 2026 to Nov 4, 2026, BIOY paid 26.1% of its starting value in cash distributions while its price fell 21.9%. With every distribution reinvested, the fund returned +5.4%. Biotech (XBI) returned +19.0% over the same days, so a holder was behind by 13.6 pts. At its price on Nov 4, 2026 the latest distribution annualizes to 60.7%, paid weekly. GraniteShares estimates that 96% of the distribution paid Sep 22, 2026 was a return of capital (its 19a-1 notice). That is a tax label, not a measure of erosion.
TYLG
Over the year to Nov 4, 2026, TYLG paid 10.2% of its starting value in cash distributions while its price rose 9.3%. With every distribution reinvested, the fund returned +20.4%. At its price on Nov 4, 2026 the latest distribution annualizes to 11.9%, paid monthly. Global X estimates that 100% of the distribution paid Sep 24, 2026 was a return of capital (its 19a-1 notice).
Questions people ask
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, BIOY against TYLG, data as of Nov 4, 2026. https://etfiq.com/compare/income/bioy-vs-tylg
ETFIQ. (Nov 4, 2026). BIOY against TYLG. Retrieved from https://etfiq.com/compare/income/bioy-vs-tylg
[BIOY against TYLG (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/income/bioy-vs-tylg)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.